Loading
Journal of Experimental Neurology
ISSN: 2692-2819
Glial Cell and Perineuronal Net Interactions in the Dorsal Striatum of Aged Mice
Elucidating how normal aging increases vulnerability to neurodegeneration remains a major gap in our understanding of disease risk and progression. The dorsal striatum serves as the primary input nucleus of the basal ganglia and is a key region implicated in multiple neurodegenerative diseases (NDDs). In Colon et al. 2025, we examined the impact of normal aging on neuroinflammatory signaling and perineuronal net (PNN) homeostasis within the dorsal striatum.
J Exp Neurol, 2026, Volume 7, Issue 2, p55-62 | DOI: 10.33696/Neurol.7.129
An Unusual Ion Channel of the TRP Family TRPV6: A Comment on the Connection of TRPV6 and Mucolipidosis Type II
Mutations in a single TRPV6 allele trigger chronic pancreatitis while loss of both alleles is responsible for skeletal dysplasia in newborns. The latter clinical presentation is accompanied by elevated serum levels of the parathyroid hormone, a condition known as transient neonatal hyperparathyroidism (TNHP). In humans, TRPV6 is abundantly expressed in the primary fetal-maternal interface in the placenta, as well as in pancreatic acini and within a few exocrine glands including salivary and lacrimal glands.
J Exp Neurol, 2026, Volume 7, Issue 2, p63-69 | DOI: 10.33696/Neurol.7.130
Pairwise External Validation of Plasma Biomarker–Based Machine Learning Models for Amyloid PET Prediction: Implications for Calibration and Clinical Utility
Blood-based biomarkers have demonstrated strong performance for identifying cerebral amyloid pathology within individual cohorts. However, their clinical utility depends on portability across populations and assay platforms. The impact of cross-cohort deployment on clinically actionable metrics such as negative predictive value remains insufficiently characterized. We analyzed data from two independent cohorts: the Alzheimer’s Disease Neuroimaging Initiative (n = 885) and the Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease study (n = 822).
J Exp Neurol, 2026, Volume 7, Issue 2, p70-89 | DOI: 10.33696/Neurol.7.131
Commentary: Expanding the Understanding of Gut Microbial Dysbiosis in Alzheimer’s Disease
Alzheimer’s disease (AD) represents a persistent and growing global health challenge. It is a progressive, and largely sporadic neurodegenerative condition characterized not only by a reduction in brain volume and weight but also by widespread and progressive atrophy of the cerebrum. The disease involves substantial loss of neurons, particularly in the hippocampus and the medial temporal lobes, as confirmed through pathological studies.
J Exp Neurol, 2026, Volume 7, Issue 2, p90-92 | DOI: 10.33696/Neurol.7.132
Resolving Glycosphingosine Isomers by Crown Ether–Assisted Ion Mobility for Neurological Lipidomics
Glycosphingosines are neuroactive lipids whose stereochemical variations are increasingly implicated in neuronal dysfunction and neurodegenerative disease processes. However, their close structural similarity renders stereoisomer-resolved analysis inaccessible to conventional LC–MS approaches, limiting mechanistic interpretation of lipid-associated neuropathology. In previous work, we demonstrated that complexation of glycosphingosine isomers with crown ethers enabled cyclic ion mobility spectrometry to resolve most of the species. Here, we investigate the energetics and structural effects of crown ether binding to interrogate the mechanism of separation enhancement.
J Exp Neurol, 2026, Volume 7, Issue 2, p93-100 | DOI: 10.33696/Neurol.7.133
Scientific Archives is a global publisher initiated with the mission of ensuring equal opportunity for accessing science to research community all over the world. Spreading research findings with great relevance to all channels without any barrier is our goal. We want to overcome the challenges of Open Access with ensured quality and transparency.